Treatment of disseminated Mycobacterium avium complex disease: a clinician's perspective.
Benson
C A
CA
Section of Infectious Disease, Rush University, Chicago, Illinois 60612, USA.
D017088:AIDS-Related Opportunistic Infections / Q000150:complications / Q000188:drug therapy*; D000163:Acquired Immunodeficiency Syndrome / Q000150:complications*; D000617:Aminoglycosides; D000900:Anti-Bacterial Agents / Q000009:adverse effects / Q000627:therapeutic use*; D000890:Anti-Infective Agents / Q000009:adverse effects / Q000627:therapeutic use; D000904:Antibiotics, Antitubercular / Q000009:adverse effects / Q000627:therapeutic use; D000995:Antitubercular Agents / Q000009:adverse effects / Q000627:therapeutic use; D002986:Clinical Trials as Topic; D016207:Cytokines / Q000627:therapeutic use; D004359:Drug Therapy, Combination; D024841:Fluoroquinolones; D006801:Humans; D018942:Macrolides; D015270:Mycobacterium avium-intracellulare Infection / Q000150:complications / Q000188:drug therapy*
D000617:Aminoglycosides; D000900:Anti-Bacterial Agents; D000890:Anti-Infective Agents; D000904:Antibiotics, Antitubercular; D000995:Antitubercular Agents; D016207:Cytokines; D024841:Fluoroquinolones; D018942:Macrolides